Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.
Wren Therapeutics has raised €34M across 2 funding rounds from 1 investor, most recently a round in Feb 2021. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKwww.wrentherapeutics.com ↗
Total raised
€34M
€34,201,209
Funding rounds
2
Investors
1
distinct backers
Active since
2019-01
latest 2021-02
Funding by year
EUR raised per yearWren Therapeutics — funding by year — interactive chart.
Data table
| Wren Therapeutics — funding by year | |
|---|---|
| 2018 | €20M |
| 2021 | €14M |
Signals
Medium confidenceRaise-next likelihood5
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 8y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-02-03 | Other | €14M | — | View deal → |
| 2019-01-01 | Series A | €20M | The Baupost Group | View deal → |